Contact
Please use this form to send email to PR contact of this press release:
Ascendis Pharma Announces Orphan Drug Designation Granted for TransCon PTH as Treatment for Hypoparathyroidism
TO:
Please use this form to send email to PR contact of this press release:
Ascendis Pharma Announces Orphan Drug Designation Granted for TransCon PTH as Treatment for Hypoparathyroidism
TO: